Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × Granulocyte-Macrophage Colony-Stimulating Factor × 1 year × Clear all

Sponsor

Conditions

Neuroblastoma 10 Brain Neoplasms 3 Recurrence 2 Osteosarcoma 2 Medulloblastoma 2 Leukemia, Myeloid, Acute 2 Glioma 2 Glioblastoma 2 Diffuse Intrinsic Pontine Glioma 2 Xanthomatosis, Cerebrotendinous 1 Wilms Tumor 1 Uveal Melanoma 1 Transplant-Related Hematologic Malignancy 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Resectable Esophageal Cancer 1 Pathologic Complete Response 1 Oligodendroglioma 1 Neoplasms 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia 1 Influenza, Human 1 Hodgkin Disease 1

Interventions

nilotinib 6 asciminib 6 Dasatinib 6 Imatinib Mesylate 5 bosutinib 4 Cyclophosphamide 4 fludarabine phosphate 3 Whole-Body Irradiation 3 ruxolitinib 2 ponatinib 2 letermovir 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Melphalan 2 Cyclosporine 2 Busulfan 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 olverembatinib 1 decitabine and cedazuridine drug combination 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Stem Cell Transplantation 1 Specimen Handling 1 Sirolimus 1 Rituximab 1 Practice Management, Medical 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡